CM Hospitalar S/A (BVMF:VVEO3)

Market Cap	473.71M
Revenue (ttm)	11.57B
Net Income (ttm)	-61.17M
Shares Out	315.81M
EPS (ttm)	-0.19
PE Ratio	n/a
Forward PE	n/a
Dividend	0.14 (8.87%)
Ex-Dividend Date	May 2, 2024

Volume	629,700
Average Volume	2,371,925
Open	1.560
Previous Close	1.580
Day's Range	1.540 - 1.580
52-Week Range	1.310 - 8.710
Beta	0.09
RSI	41.18
Earnings Date	Mar 27, 2025

About CM Hospitalar S/A

CM Hospitalar S/A engages in the distribution of hospital materials, medicines, and nutrition products in Brazil. The company offers ophthalmic agent, adrenergic and thrombopoietin agonist, aminoglycosides, painkiller, anesthetics, receptor antagonist, anti-hemorrhoidal, antihypertensives, systemic antihistamine, and orthopedic therapy materials; and anti-inflammatories, anti-TNF, antacid, antiandrogen, antianemic, anti-asthmatic, antibiotic, anticoagulant, anticonvulsant, monoclonal antibody, anti-growth, antidepressant, antidiabetic, antidiur...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 2010
• Employees: 6,000
• Stock Exchange: Brazil Stock Exchange
• Ticker Symbol: VVEO3

Financial Performance

In 2023, CM Hospitalar S/A's revenue was 11.08 billion, an increase of 26.72% compared to the previous year's 8.75 billion. Earnings were 359.92 million, an increase of 38.57%.